Unleash Immuno Oncolytics is a startup based in the United States.
Unleash Immuno Oncolytics is a startup based in the United States.
Unleash Immuno Oncolytics develops armed oncolytic viruses that target both tumor cells and tumor-associated stromal cells to disrupt tumor architecture and activate systemic immune responses against cancer.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.